Pharmexa: Presentation at ASCO on June 4, 2007

Summary: The presentation concerns Pharmexa’s RAS peptide vaccines in patients with resectable pancreatic cancer

Professor Trond Buanes from Ullevål University Hospital in Norway will on Monday June 4, 2007 present a poster titled “RAS peptide vaccination in resected pancreatic cancer patients - persistence of anti tumour response and long term survival” at ASCO’s (American Society of Clinical Oncology) annual cancer meeting.

The data concerns treatment of patients with resectable pancreatic cancer with two peptide vaccines aimed at a specific cancer mutation known as RAS. Rights to these vaccines belong to Pharmexa.

The 2007 ASCO conference will take place from June 1 to June 5 in Chicago, Illinois. It is widely regarded as the most important cancer conference in the world and attracted around 30,000 attendants last year.